The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Perrotti F, Rosa C, Cicalini I, et al. Advances in lipidomics for cancer biomarkers discovery. Int J Mol Sci. 2016;17(12):1992. doi:10.3390/ijms17121992
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498–1503. doi:10.1038/nm.2492
   PubMed Web of Science ®Google Scholar
• Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer. 2009;124(12):2938–2941. doi:10.1002/ijc.24285
   PubMed Web of Science ®Google Scholar
• Agnoli C, Grioni S, Sieri S, et al. Colorectal cancer risk and dyslipidemia: a case-cohort study nested in an Italian multicentre cohort. Cancer Epidemiol. 2014;38(2):144–151. doi:10.1016/j.canep.2014.02.002
   PubMed Web of Science ®Google Scholar
• Wuermli L, Joerger M, Henz S, et al. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis. 2005;8(4):316–320. doi:10.1038/sj.pcan.4500834
   PubMed Web of Science ®Google Scholar
• Arthur R, Møller H, Garmo H, et al. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer Med. 2016;5(6):1307–1318. doi:10.1002/cam4.665
   PubMed Web of Science ®Google Scholar
• Raju K, Punnayanapalya SS, Mariyappa N, Eshwarappa SM, Anjaneya C, Kai LJ. Significance of the plasma lipid profile in cases of carcinoma of cervix: a tertiary hospital based s tudy. Asian Pac J Cancer Prev. 2014;15(8):3779–3784. doi:10.7314/APJCP.2014.15.8.3779
   PubMedGoogle Scholar
• Sun Y, Meng H, Jin Y, et al. Serum lipid profile in gynecologic tumors: a retrospective clinical study of 1550 patients. Eur J Gynaecol Oncol. 2016;37(3):348–352.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hu QY, Piao YF, Hua YH. Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcino ma patients. Onco Targets Ther. 2016;9:2585–2591. doi:10.2147/OTT.S98079
   PubMed Web of Science ®Google Scholar
• Zhu F, Xu X, Shi B, et al. The positive predictive value of low-density lipoprotein for recurrence-free survival in ovarian canc er. Int J Gynaecol Obstet. 2018;143(2):232–238. doi:10.1002/ijgo.12645
   PubMed Web of Science ®Google Scholar
• Chi PD, Liu W, Chen H, et al. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One. 2014;9(3):e91080. doi:10.1371/journal.pone.0091080
   PubMed Web of Science ®Google Scholar
• Fan Y, Ding X, Wang J, et al. Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast ca ncer but not non-TNBCs. Int J Biol Markers. 2015;30(2):e200–e207. doi:10.5301/jbm.5000143
   PubMed Web of Science ®Google Scholar
• Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–1613. doi:10.1200/JCO.2000.18.8.1606
   PubMed Web of Science ®Google Scholar
• Rotman M, Sedlis A, Piedmonte MR, et al. A Phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169–176. doi:10.1016/j.ijrobp.2005.10.019
   PubMed Web of Science ®Google Scholar
• Vernieri C, Casola S, Foiani M, Pietrantonio F, de Braud F, Longo V. Targeting cancer metabolism: dietary and pharmacologic interventions. Cancer Discov. 2016;6(12):1315–1333. doi:10.1158/2159-8290.CD-16-0615
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Ginsberg HN, Amarenco P, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of c ardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345–1361. doi:10.1093/eurheartj/ehr112
   PubMed Web of Science ®Google Scholar
• Ulmer H, Borena W, Rapp K, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer. 2009;101(7):1202–1206. doi:10.1038/sj.bjc.6605264
   PubMed Web of Science ®Google Scholar
• Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadóttir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev. 1997;6(11):863–873.
   PubMed Web of Science ®Google Scholar
• Yang X, Ma RC, So WY, et al. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hon g Kong Diabetes Registry. Cancer. 2011;117(4):862–871. doi:10.1002/cncr.25455
   PubMed Web of Science ®Google Scholar
• Allott EH, Howard LE, Cooperberg MR, et al. Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2349–2356. doi:10.1158/1055-9965.EPI-14-0458
   PubMed Web of Science ®Google Scholar
• Lofterød T, Mortensen ES, Nalwoga H, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival b y breast cancer subtypes. BMC Cancer. 2018;18(1):654. doi:10.1186/s12885-018-4568-2
   PubMed Web of Science ®Google Scholar
• Vernieri C, Pusceddu S, Fuc G, et al. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendo crine tumors (pNETs). Int J Cancer. 2019;144(7):1704–1712. doi:10.1002/ijc.32042
   PubMed Web of Science ®Google Scholar
• Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable p ancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter C ohort study. Ann Surg. 2019;270(1):139–146. doi:10.1097/SLA.0000000000002660
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological O utcomes in colorectal cancer. Ann Surg. 2020;272(2):342–351. doi:10.1097/SLA.0000000000003239
   PubMed Web of Science ®Google Scholar